20 Dividend Stocks That Billionaires Are Piling On
Numerous billionaire money managers, including the likes of Warren Buffett and Ken Fisher, absolutely love dividend stocks (check out a list of Ken Fisher......(read more)
Posts Tagged ‘AbbVie Inc (ABBV)’
Hedge Fund and Insider Trading News: George Soros, Paulson & Co., AbbVie Inc (ABBV), Seagate Technology PLC (STX), Alliance Data Systems Co. (ADS), and More
George Soros Bought These 2 Healthcare Stocks in the Third Quarter (The Motley Fool) Although billionaire superinvestor George Soros may no longer be......(read more)
Market Movers Today: Omeros Corporation (OMER), AbbVie Inc (ABBV), Darden Restaurants, Inc. (DRI), Odyssey Marine Exploration Inc (OMEX), and More
Omeros Corporation (NASDAQ:OMER) (MarketWatch) Omeros Corp. OMER, +36.60% shares surged 45% in extremely heavy morning trade Thursday on a new government......(read more)
Hedge Fund and Insider Trading News: Elliott Management, Marcato Capital Management, CBRE Group Inc (CBG), AbbVie Inc (ABBV), Neogen Corporation (NEOG), and More
Elliott Buys Tiny Stake in Wipro in First India IT Firm Holding (Bloomberg) Billionaire Paul Singer’s Elliott Management Corp. has bought a stake in......(read more)
Flowhub is Automating Cannabis From Seed to Sale
There is no doubt that the marijuana industry in the US has a lot of growth potential. The sale of medical and recreational weed is expected to reach $......(read more)
Market Movers Today: Devon Energy Corp (DVN), Vonage Holdings Corp. (VG), Quad/Graphics, Inc. (QUAD), La-Z-Boy Incorporated (LZB), and More
Devon Energy Corp (NYSE:DVN) (MarketWatch) Shares of Devon Energy Corp. DVN, -10.16% fell 6% in premarket trading Wednesday, after the company posted......(read more)
Market Movers Today: AbbVie Inc (ABBV), Intel Corporation (INTC), Wynn Resorts, Limited (WYNN), and More
AbbVie Inc (NYSE:ABBV) (CNBC) AbbVie, the maker of the world’s best selling drug, reported fourth-quarter profit on Friday that beat Wall Street......(read more)
15 Best Selling Most Profitable Drugs of All Time
Curious to know which treatments are among the 15 bestselling most profitable drugs of all time? The pharmaceutical industry has been a topic of interest......(read more)
Top 10 Largest Pharmaceutical Companies By Revenue in 2017
The top 10 largest pharmaceutical companies by revenue in 2017 are leading companies that have a large geographical presence, loyal customer base and......(read more)
15 Biggest Healthcare Companies in USA
If you’re seeking to invest in stocks with great long-term potential and are interested in adding some exposure to the healthcare sector, then the......(read more)
This Fund’s Picks Gained 200% In A Year And Why No One Knows About It
You probably haven’t heard of Alex Denner‘s Sarissa Capital Management, which is a shame, as the fund is coming off a first-quarter in which......(read more)
10 Most Advanced Technologies In The World Today
Let’s focus on the 10 most advanced technologies in the world today, to highlight the great job done by our scientists and innovators. Technology paints......(read more)
In A Blow To AbbVie Inc (ABBV) Humira, Market For Biosimilars Opened Wide
Two patents that AbbVie Inc (NYSE:ABBV) held on Humira, a treatment for arthritis, have been invalidated by an English court. The ruling was in favor......(read more)
AbbVie Inc (ABBV) In Share Buyback Plan For The Third Year In A Row
The AbbVie Inc (NYSE:ABBV) board of directors has given the authorization required to increase $5 billion to the company’s existing share buyback program......(read more)
UK National Institute For Health And Care Excellence Rejects Leukemia Drug From AbbVie Inc (ABBV)
The National Institute for Health and Care Excellence has refused to authorize AbbVie Inc (NYSE:ABBV)‘s Venclyxto on NHS. Besides the price, the......(read more)
Here’s What’s Important About The Latest AbbVie Inc (ABBV) Approval
AbbVie Inc (NYSE:ABBV) just announced that it has picked up approval for one of its lead development candidates, but the company has failed to really......(read more)
12 Health Benefits of Medical Marijuana According To Publicly Traded Weed Companies
Yes, you read the title right there are at least 12 health benefits of medical marijuana according to publicly traded weed companies. Just keep on reading......(read more)
Emergent Technologies’ Pure MHC Explores A New Collaboration With AbbVie Inc (ABBV)
AbbVie Inc (NYSE:ABBV) has sought a joint venture with its target discovery portfolio company, Emergent Technologies Inc, Pure MHC. The collaboration......(read more)
Mylan NV (MYL), AbbVie Inc (ABBV) Sanofi SA (ADR) (SNY) In Spotlight Over Price Hikes
A Vermont drug price transparency bill threatens to make it hard for drug makers to increase drug prices without explanations. The bill seeks to shed......(read more)
Billionaire Druckenmiller’s Top Dividend Stock Picks
Stanley Druckenmiller was one of the fund managers for the Quantum Fund founded by George Soros. Ranked 128th on Forbes’ list of the richest people......(read more)
AbbVie Inc (ABBV) Awaits NDA Approval For Hepatitis C Treatment
A New Drug Application (NDA) by AbbVie Inc (NYSE:ABBV) that will be used for the treatment of Hepatitis C is at the mercy the U.S. Food and Drug Administration......(read more)
Billionaire Larry Robbins Knows How To Pick Mega-Cap Stocks
Larry Robbins’ Glenview Capital Management reported an equity portfolio worth over $13.98 billion in its latest 13F filing. The fund has a heavy......(read more)
Billionaire Larry Robbins Confidently Piles Into CBS, Anthem, As Merger Battles Continue
Larry Robbins is a billionaire investor and businessman who founded the New York-based hedge fund Glenview Capital in 2000. Mr. Robbins worked in Leon......(read more)
Gilead Sciences, Inc. (GILD) Takes Lead Against AbbVie Inc (ABBV) On Crohn’s Disease Treatment
Gilead Sciences, Inc. (NASDAQ:GILD) might as well have quashed rumors making waves claiming it is planning to acquire Belgium-based Galapagos NV (ADR) (......(read more)
December 2016 Stock Considerations
The final ‘stock considerations’ post of 2016 is finally at hand. At the beginning of the year it’s sometimes hard to imagine what the next twelve......(read more)
AbbVie Inc (ABBV) Wins Patent Battle Against Coherus Biosciences Inc (CHRS)
The US Patent and Trademark Office (USPTO) Patent Trial and Appeal Board (PTAB) has decided not to embark on the review of the 166 formulation patent......(read more)
AbbVie Inc (ABBV) Stock: Skyrocketing On IP Chatter | Coherus Biosciences Inc (CHRS) Stock Tanking
AbbVie Inc (NYSE:ABBV) and Coherus Biosciences Inc (NASDAQ:CHRS) were both off to a relatively normal start in the market today. While both were trading......(read more)
November 2016 Stock Considerations
As we near the home stretch of 2016 it seems like Mr. Market wants to give us some better buying opportunities compared to the recent months that have......(read more)
Trending Stocks: Davita, Nordstrom, AbbVie, and More
Despite the fact that the polls are narrowing and November 8 is just over a week away, the markets are rather calm, as all three indexes are moderately......(read more)
Four Dividend Champions On Sale
I usually look at dividend growth stocks and their dividend increases every week, as part of my portfolio monitoring process. In this weekly review,......(read more)
Recent Stock Purchase II October 2016
I always end my ‘Recent Buys’ posts with the caveat that Mr. Market can always spring up some new opportunities not outlined in my monthly considerations......(read more)
VeriFone (PAY), Genesco (GCO): Analysts Slashed Their Price Targets On These 5 Stocks Last Week
Although the fundamental prospects for many companies are strong given the robust U.S. economy and low unemployment rate, some analysts became quite a......(read more)
AbbVie Inc (ABBV) Expected To Launch Zinbryta In The US This Month
AbbVie Inc (NYSE:ABBV) and Biogen Inc (NASDAQ:BIIB) drug Zinbryta was approved by the Food and Drug Administration (FDA) as a therapy for adults suffering......(read more)
M&A Smorgasbord for NextEra, Plus Earnings Results from Exxon, AbbVie, 2 Other Companies
The Nasdaq and all other major indexes are in the red this morning despite tech heavyweights Amazon.com, Inc. (NASDAQ:AMZN) and Alphabet Inc (NASDAQ......(read more)
Finding Reliable 3%+ Dividends in Today’s Market: AbbVie Inc (ABBV)
Today, long term investors are challenged in navigating the course and lining up that long drive for a investment that will provide them a better than......(read more)
Why Are These Stocks in the Red Today?
After opening flat, the three indexes have sold off again. The Dow, S&P and NASDAQ are each off around 0.6%, while crude futures are down twice as......(read more)
Why Adamis Pharmaceuticals, Immunomedics and Three Other Stocks Are Deep in Red Today?
Markets are trading higher on Monday, as HSBC Holdings PLC said in a report earlier today that the markets are poised to remain bullish. However, some......(read more)
Five Dividend Stocks Hedge Funds Love
Oil baron and America’s first billionaire John D. Rockefeller once said, ‘do you know the only thing that gives me pleasure? It’s to......(read more)
Billionaire Larry Robbins’ Top Healthcare Picks for Q2
Larry Robbins‘ Glenview Capital has been underperforming the broader market and the overall hedge fund industry for over a year now. However, this......(read more)
Stumbling Biotech Stocks Spell Doom for Baker Bros. Advisors
While several hedge funds have suffered enormous losses this year due to their investments in biotech stocks, the performance of the leading biotech-focused......(read more)
Why These 5 Stocks Are Trending Today
The markets are trading in the red today after investor sentiment was dented following the Labor Department’s assertion that the U.S economy inched......(read more)
Tipp Hill Cashes Out of Gold Stocks, Puts It Into Healthcare
Syracuse University graduate Richard L. Haydon named his fund after the Tipperary Hill area, his childhood neighborhood. Before establishing Tipp Hill......(read more)
Why Are Investors Excited About These 5 Stocks Today?
The markets are going nowhere today, after the IMF cut its global growth forecast for the fourth time over the past twelve months, due to China’......(read more)
Stocks Financial Advisors Are Interested In: Costco, Facebook & More
Last week was marked by the S&P 500 entering into its eighth year of bull run amid an increase in oil prices and hopes of more stimulus from central......(read more)
Do Hedge Funds Love AbbVie Inc (ABBV)?
After years of low interest rates, retail investors continue to starve for income while awaiting higher yields. The long-lasting low interest rate environment......(read more)
Five Dividend Aristocrats Hedge Funds Are Bullish On
Amid the latest market volatility, dividend investing is one of the safest bets on the equity markets. Large investors select dividend stocks not just......(read more)
AbbVie Inc (ABBV): A Cheap Dividend Aristocrat Yielding Over 4%
AbbVie Inc (NYSE:ABBV) is one of the more controversial dividend aristocrats for several reasons. As a relatively new spin-off (2013), the company has......(read more)
The Stock Picks of This Obscure Hedge Fund Returned 70.5% In 2015; See What It’s Betting On in 2016
Although Los Angeles-based, biotech-focused hedge fund DAFNA Capital Management has been in operation for the past 17 years, chances are that very few......(read more)
Healthcare-focused Baker Bros. Advisors’ Top Picks: Incyte, Alexion, ACADIA & More
Baker Bros. Advisors is a New York City-based fund launched in 2000 by Julian and Felix Baker. The firm focuses on life science and biotechnology companies......(read more)
Billionaire Larry Robbins’ Big Q4 Moves in Humana Inc. (HUM), CIGNA Corporation (CI) and Others
Billionaire Larry Robbins, the founder of Glenview Capital Management, has been among the most scrutinized and closely-watched hedge fund managers in......(read more)
